Faes Farma, S.A. (LON:0K9H)

Faes Farma Statistics

Total Valuation

Faes Farma has a market cap or net worth of GBP 1.22 billion. The enterprise value is 1.19 billion.

Market Cap	1.22B
Enterprise Value	1.19B

Important Dates

The next estimated earnings date is Monday, October 27, 2025.

Earnings Date	Oct 27, 2025
Ex-Dividend Date	Jul 3, 2025

Share Statistics

Current Share Class	311.26M
Shares Outstanding	n/a
Shares Change (YoY)	-0.10%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.27%
Owned by Institutions (%)	8.33%
Float	235.51M

Valuation Ratios

The trailing PE ratio is 13.48 and the forward PE ratio is 16.93.

PE Ratio	13.48
Forward PE	16.93
PS Ratio	2.61
PB Ratio	1.95
P/TBV Ratio	2.78
P/FCF Ratio	18.11
P/OCF Ratio	14.04
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.41, with an EV/FCF ratio of 17.76.

EV / Earnings	13.22
EV / Sales	2.53
EV / EBITDA	11.41
EV / EBIT	13.51
EV / FCF	17.76

Financial Position

The company has a current ratio of 2.29, with a Debt / Equity ratio of 0.11.

Current Ratio	2.29
Quick Ratio	1.45
Debt / Equity	0.11
Debt / EBITDA	0.70
Debt / FCF	1.07
Interest Coverage	234.86

Financial Efficiency

Return on equity (ROE) is 14.83% and return on invested capital (ROIC) is 8.22%.

Return on Equity (ROE)	14.83%
Return on Assets (ROA)	6.92%
Return on Invested Capital (ROIC)	8.22%
Return on Capital Employed (ROCE)	12.46%
Revenue Per Employee	246,102
Profits Per Employee	47,674
Employee Count	1,775
Asset Turnover	0.59
Inventory Turnover	1.31

Taxes

Income Tax	-4.05M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.20% in the last 52 weeks. The beta is 0.36, so Faes Farma's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	+21.20%
50-Day Moving Average	4.27
200-Day Moving Average	4.06
Relative Strength Index (RSI)	67.72
Average Volume (20 Days)	5,302

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Faes Farma had revenue of GBP 466.12 million and earned 90.30 million in profits. Earnings per share was 0.29.

Revenue	466.12M
Gross Profit	301.62M
Operating Income	87.17M
Pretax Income	85.97M
Net Income	90.30M
EBITDA	100.42M
EBIT	87.17M
Earnings Per Share (EPS)	0.29

Balance Sheet

The company has 95.68 million in cash and 71.81 million in debt, giving a net cash position of 23.87 million.

Cash & Cash Equivalents	95.68M
Total Debt	71.81M
Net Cash	23.87M
Net Cash Per Share	n/a
Equity (Book Value)	625.79M
Book Value Per Share	2.01
Working Capital	204.40M

Cash Flow

In the last 12 months, operating cash flow was 86.70 million and capital expenditures -19.48 million, giving a free cash flow of 67.22 million.

Operating Cash Flow	86.70M
Capital Expenditures	-19.48M
Free Cash Flow	67.22M
FCF Per Share	n/a

Margins

Gross margin is 64.71%, with operating and profit margins of 18.70% and 19.37%.

Gross Margin	64.71%
Operating Margin	18.70%
Pretax Margin	18.44%
Profit Margin	19.37%
EBITDA Margin	21.54%
EBIT Margin	18.70%
FCF Margin	14.42%

Dividends & Yields

This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 2.81%.

Dividend Per Share	0.12
Dividend Yield	2.81%
Dividend Growth (YoY)	16.19%
Years of Dividend Growth	n/a
Payout Ratio	46.39%
Buyback Yield	0.10%
Shareholder Yield	2.92%
Earnings Yield	7.42%
FCF Yield	5.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on April 7, 2015. It was a forward split with a ratio of 1.02.

Last Split Date	Apr 7, 2015
Split Type	Forward
Split Ratio	1.02

Scores

Faes Farma has an Altman Z-Score of 3.97 and a Piotroski F-Score of 4.

Altman Z-Score	3.97
Piotroski F-Score	4